2022 - Research.com Best Female Scientist Award
Helga Refsum mainly focuses on Internal medicine, Homocysteine, Endocrinology, B vitamins and Risk factor. Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery. Her research in Homocysteine intersects with topics in Diabetes mellitus, Pregnancy, Methylenetetrahydrofolate reductase and Blood plasma.
Her research integrates issues of Homocystinuria, Methionine and Disease in her study of Endocrinology. Her B vitamins research includes themes of Randomized controlled trial and Dementia, Cognitive decline. Her Risk factor research is multidisciplinary, incorporating elements of Epidemiology, Oncology, Cardiology, Case-control study and Vascular disease.
Internal medicine, Homocysteine, Endocrinology, B vitamins and Vitamin B12 are her primary areas of study. In her research, Confidence interval and Coronary artery disease is intimately related to Gastroenterology, which falls under the overarching field of Internal medicine. Her Homocysteine study integrates concerns from other disciplines, such as Vitamin, Surgery, Methylenetetrahydrofolate reductase and Methionine.
Her study in Endocrinology is interdisciplinary in nature, drawing from both Cystathionine beta synthase, Cysteine and Fatty acid. Her research investigates the connection with B vitamins and areas like Dementia which intersect with concerns in Cerebral atrophy. The Risk factor study which covers Prospective cohort study that intersects with Cohort study.
Her scientific interests lie mostly in Internal medicine, Endocrinology, Homocysteine, B vitamins and Dementia. Her research in Internal medicine intersects with topics in Cysteine and Methionine. Within one scientific family, Helga Refsum focuses on topics pertaining to Eicosapentaenoic acid under Endocrinology, and may sometimes address concerns connected to Clinical Dementia Rating and Omega 3 fatty acid.
She interconnects Vitamin, Randomized controlled trial, Vitamin B12 and Methylenetetrahydrofolate reductase in the investigation of issues within Homocysteine. Her B vitamins research is multidisciplinary, incorporating perspectives in Cognition, Hyperhomocysteinemia, Atrophy and Cognitive decline. Her work carried out in the field of Dementia brings together such families of science as Psychiatry, Gerontology and Risk factor.
Her primary areas of investigation include Internal medicine, Homocysteine, Endocrinology, B vitamins and Methionine. Helga Refsum mostly deals with Neopterin in her studies of Internal medicine. Her Homocysteine research is multidisciplinary, relying on both Vitamin B12, Methionine synthase, Randomized controlled trial, Vitamin and Dementia.
Helga Refsum combines subjects such as Amino acid, Glutamine, Biochemistry, Fatty acid and Cerebral atrophy with her study of Endocrinology. Her B vitamins research integrates issues from Atrophy and Cognitive decline. The study incorporates disciplines such as Adipose tissue, Cobalamin, Taurine and Intrinsic factor in addition to Methionine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project.
Graham Im;Daly Le;Refsum Hm;Robinson K.
JAMA (1997)
Homocysteine and Cardiovascular Disease
H. Refsum;P. M. Ueland;O. Nygård;S. E. Vollset.
Annual Review of Medicine (1998)
Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
R. Clarke;R. Collins;S. Lewington;A. Donald.
JAMA (2002)
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Ottar Nygård;Jan Erik Nordrehaug;Helga Refsum;Per Magne Ueland.
The New England Journal of Medicine (1997)
Total homocysteine in plasma or serum: methods and clinical applications.
P M Ueland;H Refsum;S P Stabler;M R Malinow.
Clinical Chemistry (1993)
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.
O Nygård;S E Vollset;H Refsum;I Stensvold.
JAMA (1995)
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
I.J. Perry;R.W. Morris;S.B. Ebrahim;A.G. Shaper.
The Lancet (1995)
Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Helga Refsum;A. David Smith;Per M. Ueland;Ebba Nexo.
Clinical Chemistry (2004)
Serum Total Homocysteine and Coronary Heart Disease
Egil Arnesen;Helga Refsum;Kaare H Bønaa;Per Magne Ueland.
International Journal of Epidemiology (1995)
Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study.
C. S. Yajnik;S. S. Deshpande;A. A. Jackson;H. Refsum;H. Refsum.
Diabetologia (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bergen
University of Washington
University of Bergen
University of Oslo
National Institutes of Health
Guy's and St Thomas' NHS Foundation Trust
Maastricht University
University of Oslo
VU University Medical Center
German Center for Neurodegenerative Diseases
University of Manchester
University of Minnesota
University of Rochester
University of Strasbourg
Chinese Academy of Sciences
Illumina (United States)
University of Groningen
University of Graz
Delft University of Technology
Ghent University Hospital
Harvard University
Heidelberg University
Virginia Commonwealth University
King's College London
Johns Hopkins University
University of Wollongong